Association of macrophage migration inhibitory factor gene promoter polymorphisms with multiple sclerosis in Turkish...

Area of Science:

• Immunogenetics
• Neurology
• Human Genetics

Background:

• Elevated macrophage migration inhibitory factor (MIF) levels are detected in the cerebrospinal fluid of multiple sclerosis patients.
• Macrophage migration inhibitory factor (MIF) plays a role in immune regulation and inflammation.

Purpose of the Study:

• To investigate the association between macrophage migration inhibitory factor (MIF) gene polymorphisms and multiple sclerosis (MS) susceptibility.
• To determine if MIF gene polymorphisms correlate with multiple sclerosis disease severity and age of onset.

Main Methods:

• Genotyping of MIF gene polymorphisms (-173 and -794 loci) in 120 relapsing-remitting multiple sclerosis patients and 120 healthy controls.
• Statistical analysis to compare genotype frequencies between patients and controls.
• Correlation analysis between MIF genotypes and clinical parameters like progression index and age of onset.

Main Results:

• A statistically significant increase in the MIF -173 CC genotype was observed in multiple sclerosis patients compared to controls.
• The MIF -173 CC genotype was associated with a significantly earlier age of disease onset.
• The MIF -794 6/7 genotype showed a lower progression index compared to the MIF -794 6/6 genotype.
• The MIF -794 5/6 genotype was linked to a later age of disease onset.

Conclusions:

• The MIF -173 CC genotype may confer susceptibility to multiple sclerosis in the white Turkish population.
• Specific MIF gene polymorphisms are associated with variations in disease onset and progression in multiple sclerosis.